Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spain

por Lopez-Vivanco, G., Salvador, J., Diez, R., López, D., De Salas-Cansado, M., Navarro, B., De la Haba-Rodríguez, J.
Publicado 2017

Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in...

por Ciruelos, EM, López-Vivanco, G, Peláez, I, Rifa, J, Santaballa, A, González, S, Segui, MA, Jara, C, Alvarez, I, Cortés-Funes, H
Publicado 2009

Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS

por Arriola, E., Paredes-Lario, A., García-Gomez, R., Diz-Tain, P., Constenla, M., García-Girón, C., Márquez, G., Reck, M., López-Vivanco, G.
Publicado 2018

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

por Roy, A, Cunningham, D, Hawkins, R, Sörbye, H, Adenis, A, Barcelo, J-R, Lopez-Vivanco, G, Adler, G, Canon, J-L, Lofts, F, Castanon, C, Fonseca, E, Rixe, O, Aparicio, J, Cassinello, J, Nicolson, M, Mousseau, M, Schalhorn, A, D'Hondt, L, Kerger, J, Hossfeld, D K, Garcia Giron, C, Rodriguez, R, Schoffski, P, Misset, J-L
Publicado 2012

1630P Effectivity and safety of anti-SARS-CoV2 vaccination in patients with lung cancer: The VAC-CaP observational study (GECP 21/01)

por Nadal, E., Moran Bueno, M.T., Rodriguez Abreu, D., Vidales Sepulveda, Z., Sala Gonzalez, M.A., Antonanzas Basa, M., Garcia Gonzalez, J.J., Diz Tain, P., Martinez Kareaga, M., Lopez Vivanco, G., Baena Espinar, J., Campos Balea, B., Cumplido Buron, D., Cerezo Gonzalez, S., Diaz, A., Guirado, M., Mielgo Rubio, X., Juan Vidal, O.J., Saigi Morgui, M., Provencio Pulla, M.
Publicado 2022